TDCowen News & Analysis
7 articles
Market Mood
UHS Stock Price Target Revised to $197, 24% Upside Anticipated
Universal Health Services (UHS) received a price target downgrade from TD Cowen on June 22, reducing it from $230 to $197 while maintaining a Buy rating. This revised target suggests a 24% upside from the stock's current levels. A recent hospital survey indicated revenue was mostly flat year-over-year, prompting lowered growth expectations for 2026 and 2027. The healthcare sector, including UHS, is expected to benefit from AI advancements, which may enhance efficiency and profit margins for large hospital operators.
Read More: UHS Stock Price Target Revised to $197, 24% Upside Anticipated
Arm Holdings (ARM) Price Target Increased to $475 by TD Cowen
On June 24, 2026, TD Cowen raised its price target on Arm Holdings plc (NASDAQ:ARM) to $475 from $265 while maintaining a Buy rating. Similarly, UBS also raised its price target to $470 from $260. BofA analyst Vivek Arya increased the firm's price target on Arm to $460 from $335, maintaining a Neutral rating. The adjustments reflect an updated forecast for the semiconductor industry's addressable market, now estimated at $2.7 trillion for 2030, up from $2.3 trillion, driven mainly by growth in memory and data centers.
Read More: Arm Holdings (ARM) Price Target Increased to $475 by TD Cowen
AEP Target Price Raised by TD Cowen to $148 Amid Growth Outlook
TD Cowen analyst Shelby Tucker has raised the price target for American Electric Power Company, Inc. (AEP) from $141 to $148, maintaining a Buy rating. The update follows first-quarter earnings reports, indicating a robust EPS growth outlook exceeding a 9% CAGR, supported by new capital projects. Scotiabank also increased its price target on AEP to $140 from $131, with shares currently trading at over a 10% P/E premium compared to peers. This assessment highlights AEP's strong potential for growth amid a competitive utility sector.
Read More: AEP Target Price Raised by TD Cowen to $148 Amid Growth Outlook
Nvidia (NVDA) stock dips 4.42% ahead of earnings report
Nvidia (NVDA) stock closed down 4.42% at $225.32 on May 15, reflecting a broader decline in semiconductor stocks. Micron fell 6.62% to $724.66, while other notable declines included Intel at $108.77 (down 6.18%) and AMD at $424.1 (down 5.69%). Despite this recent downturn, Nvidia's CFROI is projected to reach 82% this year, but UBS warns that achieving sustained returns above 50% is rare among global stocks. The upcoming Q1 fiscal year 2027 earnings on May 20 are generating anxiety among investors, as Nvidia historically experiences stock volatility post-earnings.
Read More: Nvidia (NVDA) stock dips 4.42% ahead of earnings report
Starbucks (SBUX) Stock Rises; TD Cowen Sees Further Gains Ahead
Starbucks (SBUX) has experienced significant growth this year, with analysts at TD Cowen expressing optimism for continued upward movement. Although specific trading volumes and price changes were not provided, the positive sentiment indicates potential gains for investors in the near future. The report underscores the company's position in the market and suggests that it may deliver further value, impacting stakeholders positively. This outlook is particularly relevant for traders and long-term investors monitoring the stock's performance.
Read More: Starbucks (SBUX) Stock Rises; TD Cowen Sees Further Gains Ahead
PTC Therapeutics (PTCT) Upgraded Following Sephience Launch Review
TD Cowen upgraded PTC Therapeutics (PTCT) based on the launch of Sephience. This upgrade indicates analyst confidence in the product's potential impact on the company’s financial performance. Such upgrades can influence investor sentiment and trading volumes. The details of the expected impact on sales or specific financial metrics were not disclosed in the article.
Read More: PTC Therapeutics (PTCT) Upgraded Following Sephience Launch Review
Stryker (SYK) stock price target reduced due to cybersecurity concerns
TD Cowen has lowered the price target for Stryker (SYK) due to potential impacts from cybersecurity issues. The new target reflects a decrease from previous estimates, highlighting increased risks in the company's operational landscape. This adjustment could influence investor sentiment and stock performance as analysts reassess the company's market position. Market watchers will be keen to observe how this development affects trading volumes and investor reactions going forward.
Read More: Stryker (SYK) stock price target reduced due to cybersecurity concerns